Representations and Warranties of the Company Clause Example with 10 Variations from Business Contracts

This page contains Representations and Warranties of the Company clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Representations and Warranties of the Company. 2.1.1Pursuant to the Securities Act. 2.1.2Pursuant to the Exchange Act. 2.2Stock Exchange Listing. 2.3No Stop Orders, etc. 2.4Disclosures in Registration Statement. 2.4.1Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure of Agreements. 2.4.3Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering Materials. 2.5Changes After Dates in Registration Statement. 2.5.1No Material Adverse Change. 2.5.2Recent Securities Transactions, etc. 2.6Disclosure...s in Commission Filings. 2.7Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding Securities. 2.10.2Securities Sold Pursuant to this Agreement. 2.11Registration Rights of Third Parties. 2.12Validity and Binding Effect of Agreements. 2.13No Conflicts, etc. 2.14No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct of Business. 2.15.2Transactions Contemplated Herein. 2.16D&O Questionnaires. 2.17Litigation; Governmental Proceedings. 2.18Good Standing. 2.19Insurance. 2.20Transactions Affecting Disclosure to FINRA. 2.20.1Finder's Fees. 2.20.2Payments Within Twelve Months. 2.20.3Use of Proceeds. 2.20.5Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' Certificate. 2.27Lock-Up Agreements. 2.28Subsidiaries. 2.29Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board of Directors. 2.31Sarbanes-Oxley Compliance. 2.31.1Disclosure Controls. 2.31.2Compliance. 2.32Accounting Controls. 2.33No Investment Company Status. 2.34No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA Compliance. 2.39Compliance with Laws. 2.41Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry Data. 2.46Margin Securities. 2.47Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality and Non-Competition. View More
Found in SECOND SIGHT MEDICAL PRODUCTS INC contract

Variations of a "Representations and Warranties of the Company" Clause from Business Contracts

Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.2 Stock Exchange Listing. 2.3No Stop Orders, etc. 2.4Disclosures 2.4 Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.4.2 Disclosure of Agreements. 2.4.3Prior 2.4.3 Regulations. 2.4.5 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering Materials. 2.5Changes 2.5 Ch...anges After Dates in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures in Commission Filings. 2.7Independent 2.6 Reserved. 2.7 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.9 Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities 2.10.2 Securities Sold Pursuant to this Agreement. 2.11Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No 2.14 No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions 2.20 Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve (12) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.22 Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.23 Anti-Money Laundering Laws. 2.24 Officers' Certificate. 2.27Lock-Up 2.25 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.27 Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board 2.28 Board of Directors. 2.31Sarbanes-Oxley 2.29 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.29.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting Controls. 2.33No 2.29.2 Compliance. 2.31 No Investment Company Status. 2.34No 2.32 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA 2.35 ERISA Compliance. 2.39Compliance with 2.37 Emerging Growth Company. 2.38 Environmental Laws. 2.41Real 2.39 Title to Property. 2.42Contracts Affecting Capital. 2.43Ineligible 2.41 Loans to Directors or Officers. 2.42 Ineligible Issuer. 2.44Reserved. 2.45Industry 2.43 Smaller Reporting Company. 2.44 Industry Data. 2.46Margin Securities. 2.47Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality 2.45 Electronic Road Show. 2.47 Forward-Looking Statements. 2.48 Integration. 2.49 Confidentiality and Non-Competition. 2.50 Corporate Records. 2.51 Diligence Materials. 2.52 Stabilization. View More
Found in Reborn Coffee, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant to the Securities Act. 2.1.2Pursuant 2.2 Pursuant to the Exchange Act. 2.2Stock 2.3 Stock Exchange Listing. 2.3No 2.4 No Stop Orders, etc. 2.4Disclosures 2.5 Disclosures in Registration Statement. 2.4.1Compliance 2.5.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.5.2 Disclosure of Agreements. 2.4.3Prior 2.5.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No 2.5.5 No Other Distribution of Offering Materials. 2.5Changes 2.6 Changes After Dates in... Registration Statement. 2.5.1No 2.6.1 No Material Adverse Change. 2.5.2Recent 2.6.2 Recent Securities Transactions, etc. 2.6Disclosures 2.7 Disclosures in Commission Filings. 2.7Independent 2.8 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.10 Authorized Capital; Options, etc. 2.10Valid 2.11 Valid Issuance of Securities, etc. 2.10.1Outstanding 2.11.1 Outstanding Securities. 2.10.2Securities Sold Pursuant to this Agreement. 2.11Registration 2.12 Registration Rights of Third Parties. 2.12Validity 2.13 Validity and Binding Effect of Agreements. 2.13No 2.14 No Conflicts, etc. 2.14No 2.15 No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.16.1 Conduct of Business. 2.15.2Transactions 2.16.2 Transactions Contemplated Herein. 2.16D&O 2.17 D&O Questionnaires. 2.17Litigation; 2.18 Litigation; Governmental Proceedings. 2.18Good 2.19 Good Standing. 2.19Insurance. 2.20Transactions 2.20 Insurance. 2.21 Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.21.1 Finder's Fees. 2.20.2Payments Within Twelve Months. 2.20.3Use 2.21.3 Use of Proceeds. 2.20.5Information. 2.21Foreign 2.21.4 FINRA Affiliation. 2.21.5 Information. 2.22 Foreign Corrupt Practices Act. 2.22Compliance 2.23 Compliance with OFAC. 2.23Forward-Looking 2.24 Money Laundering Laws. 2.25 Forward-Looking Statements. 2.25Regulatory. 2.26Officers' Certificate. 2.27Lock-Up 2.27 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.28 Subsidiaries. 2.29 Related Party Transactions. 2.29.1Business 2.29.1 Business Relationships. 2.29.2No 2.29.2 No Relationships with Customers and Suppliers. 2.29.3No 2.29.3 No Unconsolidated Entities. 2.29.4No 2.29.4 No Loans or Advances to Affiliates. 2.30Board 2.30 Board of Directors. 2.31Sarbanes-Oxley 2.31 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.31.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.32 Accounting Controls. 2.33No 2.33 No Investment Company Status. 2.34No 2.34 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA Compliance. 2.39Compliance 2.36 Taxes. 2.37 Compliance with Environmental Laws. 2.39 Compliance with Laws. 2.41Real 2.40 Smaller Reporting Company. 2.42 Margin Securities. 2.43 Clinical Studies. 2.44 Integration. 2.45 Title to Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry Data. 2.46Margin Securities. 2.47Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality and Non-Competition. 2.47 Corporate Records. View More
Found in Advaxis, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.2 Stock Exchange Listing. 2.3No Stop Orders, etc. 2.4Disclosures 2.4 Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure of Agreements. 2.4.3Prior 2.4.3 Regulations. 2.4.5 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering Materials. 2.5Changes 2.5 Changes After Dates... in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures in Commission Filings. 2.7Independent 2.6 Reserved. 2.7 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.9 Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities 2.10.2 Securities Sold Pursuant to this Agreement. 2.11Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No 2.14 No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions 2.20 Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve (12) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.22 Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.23 Anti-Money Laundering Laws. 2.24 Officers' Certificate. 2.27Lock-Up 2.25 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.27 Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board 2.28 Board of Directors. 2.31Sarbanes-Oxley 2.29 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.29.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting Controls. 2.33No 2.29.2 Compliance. 2.31 No Investment Company Status. 2.34No 2.32 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA 2.33 Intellectual Property Rights. 2.35 ERISA Compliance. 2.39Compliance 2.36 Compliance with Laws. 2.41Real 2.38 Environmental Laws. 2.39 Title to Property. 2.42Contracts Affecting Capital. 2.43Ineligible 2.41 Loans to Directors or Officers. 2.42 Ineligible Issuer. 2.44Reserved. 2.45Industry 2.43 Smaller Reporting Company. 2.44 Industry Data. 2.46Margin 2.45 Electronic Road Show. 2.46 Margin Securities. 2.47Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality 2.48 Integration. 2.49 Confidentiality and Non-Competition. 2.50 Corporate Records. 2.51 Diligence Materials. 2.52 Stabilization. View More
Found in Yoshiharu Global Co. contract
Representations and Warranties of the Company. 2.1.1Pursuant to the Securities Act. 2.1.2Pursuant 2.2 Pursuant to the Exchange Act. 2.2Stock 2.3 Stock Exchange Listing. 2.3No 2.4 No Stop Orders, etc. 2.4Disclosures 2.5Disclosures in Registration Statement. 2.4.1Compliance 2.5.1Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.5.2 Disclosure of Agreements. 2.4.3Prior 2.5.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No 2.5.4 Regulations. 2.5.5 No Other Distribution of Offering Materials. 2.5Changes 2.6Change...s After Dates in Registration Statement. 2.5.1No 2.6.1 No Material Adverse Change. 2.5.2Recent 2.6.2 Recent Securities Transactions, etc. 2.6Disclosures 2.7 Disclosures in Commission Filings. 2.7Independent 2.8 Independent Accountants. 2.8Financial 2.9 Financial Statements, etc. 2.9Authorized 2.10 Authorized Capital; Options, etc. 2.10Valid 2.11Valid Issuance of Securities, etc. 2.10.1Outstanding 2.11.1 Outstanding Securities. 2.10.2Securities 2.11.2 Securities Sold Pursuant to this Agreement. 2.11Registration 2.12 Registration Rights of Third Parties. 2.12Validity 2.13 Validity and Binding Effect of Agreements. 2.13No 2.14 No Conflicts, etc. 2.14No 2.15 No Defaults; Violations. 2.15Corporate Violations; Customers and Suppliers. 2.16Corporate Power; Licenses; Consents. 2.15.1Conduct 2.16.1 Conduct of Business. 2.15.2Transactions 2.16.2 Transactions Contemplated Herein. 2.16D&O 2.17 D&O Questionnaires. 2.17Litigation; 2.18 Litigation; Governmental Proceedings. 2.18Good 2.19 Good Standing. 2.19Insurance. 2.20Transactions 2.20 Insurance. 2.21Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.21.1 Finder's Fees. 2.20.2Payments 2.21.2 Payments Within Twelve Six (6) Months. 2.20.3Use 2.21.3 Use of Proceeds. 2.20.5Information. 2.21Foreign 2.21.4 FINRA Affiliation. 2.21.5 Information. 2.22 Foreign Corrupt Practices Act. 2.22Compliance 2.23 Compliance with OFAC. 2.23Forward-Looking 2.24 Money Laundering Laws. 2.25 Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.26 Officers' Certificate. 2.27Lock-Up 2.27 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related Party Transactions. 2.29.1Business 2.28 Subsidiaries. 2.29.1 Business Relationships. 2.29.2No 2.29.2 No Relationships with Customers and Suppliers. 2.29.3No 2.29.3 No Unconsolidated Entities. 2.29.4No 2.29.4 No Loans or Advances to Affiliates. 2.30Board 2.30 Board of Directors. 2.31Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.31.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.31.2 Compliance. 2.32 Accounting Controls. 2.33No 2.33 No Investment Company Status. 2.34No 2.34 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA 2.35 Intellectual Property Rights. 2.36 Taxes. 2.38 ERISA Compliance. 2.39Compliance 2.39 Compliance with Laws. 2.41Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry 2.40 Smaller Reporting Company. 2.41 Industry Data. 2.46Margin 2.42 Margin Securities. 2.47Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality 2.43 Integration. 2.44 Title. 2.45 Confidentiality and Non-Competition. View More
Found in Verb Technology Company, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.2 Stock Exchange Listing. 2.3No 2.3 No Stop Orders, etc. 2.4Disclosures 2.4 Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure of Agreements. 2.4.3Prior 2.4.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No 2.4.4 Regulations. 2.4.5 No Other Distribution of Offering Materials. 2.5Changes 2.5 Cha...nges After Dates in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent Securities Transactions, etc. 2.6Disclosures 2.6 Disclosures in Commission Filings. 2.7Independent 2.7 Independent Accountants. 2.8Financial 2.8 Financial Statements, etc. 2.9Authorized Capital; Options, etc. 2.10Valid 2.10 Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities 2.10.2 Securities Sold Pursuant to this Agreement. 2.11Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No 2.14 No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.19 Insurance. 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve (12) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.21 Foreign Corrupt Practices Act. 2.22Compliance 2.22 Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.24 Money Laundering Laws. 2.25 Officers' Certificate. 2.27Lock-Up 2.26 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.27 Subsidiaries. 2.28 Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board 2.29 Board of Directors. 2.31Sarbanes-Oxley 2.30.1 Disclosure Controls. 2.30.2 Compliance. 2.31.1Disclosure 2.31 Accounting Controls. 2.31.2Compliance. 2.32Accounting Controls. 2.33No 2.32 No Investment Company Status. 2.34No 2.33 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA Compliance. 2.39Compliance 2.35 Taxes. 2.37 Compliance with Laws. 2.41Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry 2.39 Smaller Reporting Company. 2.40 Industry Data. 2.46Margin 2.41 Margin Securities. 2.47Exchange 2.42 Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No 2.43 Electronic Road Show. 2.44 Integration. 2.46 Confidentiality and Non-Competitions. 2.47 Corporate Records. 2.48 No Stabilization. 2.51Confidentiality and Non-Competition. 2.49 Environmental Laws. 2.51 Regulatory Filings. 2.52 Compliance with Health Care Laws. 2.54 eXtensible Business Reporting Language. View More
Found in Citius Pharmaceuticals, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.1.3 S-3 Eligibility. 2.2 Stock Exchange Listing. 2.3No 2.3 No Stop Orders, etc. 2.4Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.4.2 Disclosure of Agreements. 2.4.3Prior 2.4.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering Materials. 2.5Changes 2.4.4 Regul...ations. 2.5 Changes After Dates in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures 2.6 Disclosures in Commission Filings. 2.7Independent 2.7 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.9 Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities 2.10.2 Securities Sold Pursuant to this Agreement. 2.11Registration 2.11 Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No Conflicts, etc. 2.14No 2.14 No Defaults; Violations. 2.15Corporate 2.15 Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions 2.19 Insurance. 2.20 Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve (12) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign 2.20.4 FINRA Affiliation. 2.21 Foreign Corrupt Practices Act. 2.22Compliance 2.22 Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.23 Money Laundering Laws. 2.24 [Intentionally Omitted.] 2.25 Officers' Certificate. 2.27Lock-Up 2.26 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.28 Related Party Transactions. 2.29.1Business 2.28.1 Business Relationships. 2.29.2No 2.28.2 No Relationships with Customers and Suppliers. 2.29.3No 2.28.3 No Unconsolidated Entities. 2.29.4No 2.28.4 No Loans or Advances to Affiliates. 2.30Board 2.29 Board of Directors. 2.31Sarbanes-Oxley 2.30 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.30.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.31 Accounting Controls. 2.33No 2.32 No Investment Company Status. 2.34No 2.33 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA 2.36 ERISA Compliance. 2.39Compliance with 2.38 Environmental Laws. 2.41Real Property. 2.42Contracts 2.40 Contracts Affecting Capital. 2.43Ineligible 2.41 Loans to Directors or Officers. 2.42 Ineligible Issuer. 2.44Reserved. 2.45Industry 2.43 Smaller Reporting Company. 2.44 Industry Data. 2.46Margin Securities. 2.47Exchange 2.46 Forward-Looking Statements. 2.47 Exchange Act Reports. 2.48Minute 2.48 Integration. 2.49 Confidentiality and Non-Competitions. 2.50 [Intentionally Omitted.] 2.51 Electronic Road Show. 2.52 Minute Books. 2.49Integration. 2.50No 2.53 Stabilization. 2.51Confidentiality and Non-Competition. View More
Found in PARETEUM Corp contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.2 Stock Exchange Listing. 2.3No Stop Orders, etc. 2.4Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure of Agreements. 2.4.3Prior 2.4.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering Materials. 2.5Changes After Dates in Registration Statement. 2.5.1No 2.4.4 Regul...ations. 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures 2.6 Disclosures in Commission Filings. 2.7Independent 2.7 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.9 Authorized Capital; Options, etc. 2.10Valid 2.10 Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities Sold Pursuant to this Agreement. 2.11Registration 2.11 Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No Defaults; Violations. 2.15Corporate 2.15 Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions 2.20 Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve (12) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.22 Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.23 Money Laundering Laws. 2.24 Officers' Certificate. 2.27Lock-Up 2.25 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.27 Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board 2.28 Board of Directors. 2.31Sarbanes-Oxley 2.29 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.29.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting Controls. 2.33No 2.29.2 Compliance. 2.31 No Investment Company Status. 2.34No 2.32 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA Compliance. 2.39Compliance 2.34 Taxes. 2.36 Compliance with Laws. 2.41Real 2.38 Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry 2.40 Loans to Directors or Officers. 2.41 Smaller Reporting Company. 2.42 Industry Data. 2.46Margin 2.43 Margin Securities. 2.47Exchange Act Reports. 2.48Minute 2.44 Forward-Looking Statements. 2.46 Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality and Non-Competition. View More
Found in Intellicheck, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant to the Securities Act. 2.1.2Pursuant to the Exchange Act. 2.1.3S-3 Eligibility. 2.2Stock Exchange Listing. 2.3No Stop Orders, etc. 2.4Disclosures in Registration Statement. 2.4.1Compliance Statement.2.4.1.Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.4.2.Disclosure of Agreements. 2.4.3Prior 2.4.3.Prior Securities Transactions. 2.4.4Regulations. 2.4.5No Other Distribution of Offering 2.4.4.Regulations. 2.4.5.Offering Materials. 2.5Changes After Dates in ...Registration Statement. 2.5.1No 2.5.1.No Material Adverse Change. 2.5.2Recent 2.5.2.Recent Securities Transactions, etc. 2.6Disclosures in Commission Filings. 2.7Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding etc.2.10.1.Outstanding Securities. 2.10.2Securities 2.10.2.Securities Sold Pursuant to this Agreement. 2.11Registration Rights of Third Parties. 2.12Validity and Binding Effect of Agreements. 2.13No Conflicts, etc. 2.14No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct Consents.2.15.1.Conduct of Business. 2.15.2Transactions 2.15.2.Transactions Contemplated Herein. 2.16D&O Questionnaires. 2.17Litigation; Governmental Proceedings. 2.18Good Standing. 2.19Insurance. 2.20Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1.Finder's Fees. 2.20.2Payments 2.20.2.Payments Within Twelve Six (6) Months. 2.20.3Use 2.20.3.Use of Proceeds. 2.20.5Information. 2.20.4.FINRA Affiliation. 2.20.5.Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance with OFAC. 2.23Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.23Money Laundering Laws. 2.24Regulatory. 2.25Officers' Certificate. 2.27Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.26Intentionally Omitted. 2.27Subsidiaries. 2.28Related Party Transactions. 2.29.1Business Relationships. 2.29.2No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No Loans or Advances to Affiliates. 2.30Board 2.29Board of Directors. 2.31Sarbanes-Oxley 2.30Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.30.1.Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.30.2.Compliance. 2.31Accounting Controls. 2.33No 2.32No Investment Company Status. 2.34No 2.33No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA 2.34Intellectual Property Rights. 2.35Taxes. 2.36ERISA Compliance. 2.39Compliance 2.37Compliance with Laws. 2.41Real 2.38Environmental Laws. 2.39Real Property. 2.42Contracts 2.40Ineligible Issuer. 2.41Industry Data. 2.42Margin Securities. 2.43Forward-Looking Statements. 2.44Contracts Affecting Capital. 2.43Ineligible Issuer. 2.44Reserved. 2.45Industry Data. 2.46Margin Securities. 2.47Exchange Act Reports. 2.48Minute 2.45Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality and Non-Competition. View More
Found in CALADRIUS BIOSCIENCES, INC. contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock 2.2 Stock Exchange Listing. 2.3No 2.3 No Stop Orders, etc. 2.4Disclosures 2.4 Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure of Agreements. 2.4.3Prior 2.4.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No 2.4.4 Regulations. 2.4.5 No Other Distribution of Offering Materials. 2.5Changes After D...ates in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures 2.6 Disclosures in Commission Filings. 2.7Independent 2.7 Independent Accountants. 2.8Financial 2.8 Financial Statements, etc. 2.9Authorized Capital; Options, etc. 2.10Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities Sold Pursuant to this Agreement. 2.11Registration 2.11 Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good Standing. 2.19Insurance. 2.19 Insurance. 2.20Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve Six (6) Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign Corrupt Practices Act. 2.22Compliance 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.22 Compliance with OFAC. 2.23Forward-Looking 2.23 Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.24 Money Laundering Laws. 2.26 Officers' Certificate. 2.27Lock-Up 2.27 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related Party Transactions. 2.29.1Business 2.29.1 Business Relationships. 2.29.2No 2.29.2 No Relationships with Customers and Suppliers. 2.29.3No 2.29.3 No Unconsolidated Entities. 2.29.4No 2.29.4 No Loans or Advances to Affiliates. 2.30Board 2.30 Board of Directors. 2.31Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.31.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.32 Accounting Controls. 2.33No 2.33 No Investment Company Status. 2.34No 2.34 No Labor Disputes. 2.36Clinical Studies. 2.37Taxes. 2.38ERISA Compliance. 2.39Compliance 2.36 Taxes. 2.38 Licenses or Permits. 2.39 Compliance with Laws. 2.41Real 2.41 Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible 2.43 Loans to Directors or Officers. 2.44 Ineligible Issuer. 2.44Reserved. 2.45Industry 2.45 Accelerated Filer. 2.46 Industry Data. 2.46Margin 2.47 Margin Securities. 2.47Exchange 2.48 Exchange Act Reports. 2.48Minute Books. 2.49Integration. 2.50No Stabilization. 2.51Confidentiality 2.50 Confidentiality and Non-Competition. 2.51 Stabilization. 2.52 Integration. View More
Found in Synthetic Biologics, Inc. contract
Representations and Warranties of the Company. 2.1.1Pursuant 2.1.1 Pursuant to the Securities Act. 2.1.2Pursuant 2.1.2 Pursuant to the Exchange Act. 2.2Stock Exchange Listing. 2.3No 2.3 No Stop Orders, etc. 2.4Disclosures 2.4 Disclosures in Registration Statement. 2.4.1Compliance 2.4.1 Compliance with Securities Act and 10b-5 Representation. 2.4.2Disclosure 2.4.2 Disclosure of Agreements. 2.4.3Prior 2.4.3 Prior Securities Transactions. 2.4.4Regulations. 2.4.5No 2.4.5 No Other Distribution of Offering Materials. 2.5Changes 2.5 Changes After D...ates in Registration Statement. 2.5.1No 2.5.1 No Material Adverse Change. 2.5.2Recent 2.5.2 Recent Securities Transactions, etc. 2.6Disclosures 2.6 Disclosures in Commission Filings. 2.7Independent 2.7 Independent Accountants. 2.8Financial Statements, etc. 2.9Authorized 2.9 Authorized Capital; Options, etc. 2.10Valid 2.10 Valid Issuance of Securities, etc. 2.10.1Outstanding 2.10.1 Outstanding Securities. 2.10.2Securities Sold Pursuant to this Agreement. 2.11Registration 2.11 Registration Rights of Third Parties. 2.12Validity 2.12 Validity and Binding Effect of Agreements. 2.13No 2.13 No Conflicts, etc. 2.14No 2.14 No Defaults; Violations. 2.15Corporate Power; Licenses; Consents. 2.15.1Conduct 2.15.1 Conduct of Business. 2.15.2Transactions 2.15.2 Transactions Contemplated Herein. 2.16D&O 2.16 D&O Questionnaires. 2.17Litigation; 2.17 Litigation; Governmental Proceedings. 2.18Good 2.18 Good Standing. 2.19Insurance. 2.20Transactions Affecting Disclosure to FINRA. 2.20.1Finder's 2.19 Insurance. 2.20.1 Finder's Fees. 2.20.2Payments 2.20.2 Payments Within Twelve Months. 2.20.3Use 2.20.3 Use of Proceeds. 2.20.5Information. 2.21Foreign 2.20.4 FINRA Affiliation. 2.20.5 Information. 2.21 Foreign Corrupt Practices Act. 2.22Compliance with OFAC. 2.23Forward-Looking 2.23 Forward-Looking Statements. 2.25Regulatory. 2.26Officers' 2.24 Money Laundering Laws. 2.25 Regulatory. 2.26 Officers' Certificate. 2.27Lock-Up 2.27 Lock-Up Agreements. 2.28Subsidiaries. 2.29Related 2.28 Subsidiaries. 2.29 Related Party Transactions. 2.29.1Business 2.29.1 Business Relationships. 2.29.2No 2.29.2 No Relationships with Customers and Suppliers. 2.29.3No Unconsolidated Entities. 2.29.4No 2.29.4 No Loans or Advances to Affiliates. 2.30Board 2.30 Board of Directors. 2.31Sarbanes-Oxley 2.31 Sarbanes-Oxley Compliance. 2.31.1Disclosure 2.31.1 Disclosure Controls. 2.31.2Compliance. 2.32Accounting 2.31.2 Compliance. 2.32 Accounting Controls. 2.33No Investment Company Status. 2.34No 2.34 No Labor Disputes. 2.36Clinical 2.35 Intellectual Property Rights. 2.36 Clinical Studies. 2.37Taxes. 2.38ERISA 2.38 ERISA Compliance. 2.39Compliance with 2.40 Environmental Laws. 2.41Real 2.41 Real Property. 2.42Contracts Affecting Capital. 2.43Ineligible 2.43 Ineligible Issuer. 2.44Reserved. 2.45Industry 2.44 Industry Data. 2.46Margin 2.45 Margin Securities. 2.47Exchange 2.46 Exchange Act Reports. 2.48Minute 2.47 Minute Books. 2.49Integration. 2.50No 2.49 No Stabilization. 2.51Confidentiality 2.50 Confidentiality and Non-Competition. View More
Found in Ampio Pharmaceuticals, Inc. contract